Healthy Participant Clinical Trial
Official title:
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants
This is a Phase 1, randomized, double-blind, placebo-controlled single ascending dose (SAD) study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of DNL919.
This clinical trial information was submitted voluntarily under the applicable law and, therefore, certain submission deadlines may not apply. (That is, clinical trial information for this applicable clinical trial was submitted under section 402(j)(4)(A) of the Public Health Service Act and 42 CFR 11.60 and is not subject to the deadlines established by sections 402(j)(2) and (3) of the Public Health Service Act or 42 CFR 11.24 and 11.44.). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05311865 -
Transmission of Covid-19 During Clubbing Events in Closed Places
|
N/A | |
| Recruiting |
NCT05520216 -
Effect of Rib Cage and Spine Mobility on Maximum Breath-Hold Time
|
||
| Active, not recruiting |
NCT04807465 -
Different Modes of Universal Adhesive in Smokers and Non-Smokers
|
N/A | |
| Completed |
NCT06087055 -
Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants
|
Phase 1 | |
| Completed |
NCT04962022 -
Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants
|
Phase 1 | |
| Completed |
NCT04962230 -
Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir
|
Phase 1 | |
| Active, not recruiting |
NCT04814836 -
Laser Etching Effect on Application Mode of Universal Adhesive
|
N/A |